A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

Clinical trial NCT05774184 · COMPLETED

Trial details

NCT number: NCT05774184
Sponsor: Celldex Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Eosinophilic Esophagitis

Start date: 2023-06-01
Primary completion: 2025-06-04
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.